≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

Endpoint Browser

C3_ACCESSORY_SINUS_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C31
  • Hospital discharge: ICD-9 — 160
  • Hospital discharge: ICD-8 — 160
  • Cause of death: ICD-10 — C31
  • Cause of death: ICD-9 — 160
  • Cause of death: ICD-8 — 160
  • Cause of death: excluded ICD-9 — 160[0-1]
  • Cause of death: excluded ICD-8 — 160[0-1]
  • Cancer registry: Topography ICD-O-3 — C31
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

165

4. Check minimum number of events

None

165

5. Include endpoints

None

165

6. Filter based on genotype QC (FinnGen only)

165

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 165 60 105
Unadjusted period prevalence (%) 0.04 0.02 0.05
Median age at first event (years) 63.51 60.63 65.15

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
76
Matched controls
758
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
38.9
34
*
C31.0
ICD-10 Finland
Malignant neoplasm: Maxillary sinus
+∞
30.2
27
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
25.4
23
*
H02AB02
ATC
dexamethasone; systemic
285.0
21.8
21
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
20.8
19
*
8070/3-C31.0
ICD-O-3
Squamous cell carcinoma, NOS, of maxillary sinus
+∞
19.6
18
*
A03FA01
ATC
metoclopramide; systemic, rectal
14.1
18.5
34
41
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
18.5
17
*
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
+∞
18.5
17
*
DHA10
NOMESCO Finland
Biopsy of cavity of nose
215.4
17.2
17
*
D38.51
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other accessory sinus
+∞
16.2
15
*
C31.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of accessory sinuses
+∞
16.2
15
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
16.2
15
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
16.2
15
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
17.3
16.2
26
22
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
8.7
15.7
41
90
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
15.1
14
*
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
183.9
15.0
15
*
N02AA05
ATC
oxycodone; systemic
11.7
14.3
28
36
UDM02
NOMESCO Finland
Sinoscopy
43.0
14.2
17
5
A04AA01
ATC
ondansetron; systemic, rectal
61.3
13.4
15
*
XX3DW
NOMESCO Finland
Time consuming IT work
22.5
13.4
19
11
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
+∞
12.9
12
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
11.8
11
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
11.8
11
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
51.5
11.3
13
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
51.5
11.3
13
*
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
51.5
11.3
13
*
JN4BD
NOMESCO Finland
Extensive body CT
22.0
11.3
16
9
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
38.6
10.7
13
*
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
126.8
10.7
11
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
10.7
10
*
L03AA02
ATC
filgrastim; parenteral
+∞
10.7
10
*
Z51.5
ICD-10 Finland
Palliative care
24.1
10.2
14
7
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
12.5
9.6
17
17
EEB00
NOMESCO Finland
Partial excision of maxilla
+∞
9.6
9
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
+∞
9.6
9
*
C31.9
ICD-10 Finland
Malignant neoplasm: Accessory sinus, unspecified
+∞
9.6
9
*
DMA00
NOMESCO Finland
Biopsy of maxillary antrum
+∞
9.6
9
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
9.6
9
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
56.8
8.9
10
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
100.8
8.6
9
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
17.1
8.6
13
9
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
8.5
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.5
8
*
D38.50
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of maxillary sinus
+∞
8.5
8
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
8.5
8
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
8.5
8
*
EEB10
NOMESCO Finland
Maxillectomy
+∞
8.5
8
*
C31.1
ICD-10 Finland
Malignant neoplasm: Ethmoidal sinus
+∞
8.5
8
*
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
+∞
8.5
8
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
+∞
8.5
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.5
8
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
8.5
8
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
8.5
8
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.6
8.4
20
34
WW500
NOMESCO Finland
Blood transfusion
20.0
8.4
12
7
SAA03
NOMESCO Finland
Extended examination of mouth
4.3
8.3
40
155
EP1AE
NOMESCO Finland
Neck ultrasound examination
17.5
8.0
12
8
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
28.4
7.8
10
*
ZXC95
NOMESCO Finland
Use of surgical navigator
88.4
7.6
8
*
DM1CG
NOMESCO Finland
Paranasal sinuses and face area extensive MRI examination with high intensity magnet
+∞
7.4
7
*
AAE99
NOMESCO Finland
Other operation by cranial base approach
+∞
7.4
7
*
GBB00
NOMESCO Finland
Tracheostomy
25.2
6.8
9
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.8
6.8
24
67
WX402
NOMESCO Finland
General anaesthesia
5.7
6.6
19
42
DPA30
NOMESCO Finland
Sphenotomy
76.0
6.5
7
*
A07AA02
ATC
nystatin; oral
7.9
6.4
14
21
SBB10
NOMESCO Finland
Teeth copy
7.9
6.4
14
21
DPB00
NOMESCO Finland
Partial excision of frontal sinus
+∞
6.3
6
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
DNB30
NOMESCO Finland
Excision of lesion of ethmoidal sinus
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
ZZQ20
NOMESCO Finland
Free microvascular graft of skin, muscle and bone
+∞
6.3
6
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
6.2
6.1
16
31

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
51
36
20.06
58.85
1.9
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
83
364
3.58
14.67
4.1
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
29
77
4.36
10.29
2.2
2.0
g/l
0.2
0.2
1.00
29
62
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
23
51
5.08
10.13
9.1
6.4
mmol/l
24.8
25.1
0.15
23
45
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
13
9.88
9.99
1.2
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
65
305
2.87
9.40
3.6
2.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
53
225
3.00
9.17
3.1
2.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
41
150
3.31
9.13
2.9
1.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
84
465
2.64
8.63
5.8
3.4
g/l
32.4
35.5
3.85
76
415
(3002256) Pathology report gross observation
26
79
3.72
7.62
1.5
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
10
5
21.15
7.22
1.2
1.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
91
558
2.41
7.09
10.4
5.5
mmol/l
1.2
1.2
0.85
75
480
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
80
464
2.41
7.07
6.0
3.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
24
76
3.53
6.60
2.2
4.6
%
0.4
0.2
0.49
19
20
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
6
0
+∞
6.28
5.8
0.0
umol/l
0.4
—
—
6
0
(3003396) Base excess in Arterial blood by calculation
33
131
2.90
6.26
8.0
6.0
mmol/l
0.8
1.6
0.33
26
102
(3042936) Bacteria identified in Isolate by Culture
38
167
2.66
5.94
2.7
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
24
83
3.21
5.74
2.3
4.4
%
1.7
0.7
0.83
18
25
(3002179) Metamyelocytes/100 leukocytes in Blood
22
73
3.32
5.62
1.9
4.8
%
2.1
0.4
1.87
13
17
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
58
3.57
5.50
1.7
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
23
80
3.18
5.45
7.5
6.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
80
504
2.14
5.41
8.6
5.0
mmol/l
1.2
1.2
0.67
72
444
(40758558) Short blood count panel - Blood
47
247
2.26
4.93
14.6
4.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
91
622
2.03
4.75
19.1
6.3
e9/l
3.9
4.2
0.58
84
545
(42870588) Differential panel, method unspecified - Blood
61
362
2.09
4.68
7.2
5.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
50
3.44
4.47
5.2
7.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
55
320
2.08
4.41
6.4
3.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
12
7.86
4.41
1.2
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
23
91
2.77
4.35
8.6
4.5
mmol/l
1.3
1.6
0.66
23
84
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
6
12.10
4.31
5.9
8.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
93
1175
0.52
3.97
4.4
4.7
mmol/l
4.7
4.5
0.85
86
1076
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
24
4.37
3.94
1.7
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
23
96
2.62
3.93
1.7
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
11
7.58
3.90
1.3
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
19
72
2.85
3.89
2.0
4.7
%
0.0
0.1
0.48
14
18
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
15
6.28
3.87
1.9
3.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
8
9.07
3.81
1.9
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
8
9.07
3.81
1.3
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
93
1167
0.53
3.72
4.5
4.6
mmol/l
1.4
1.4
0.07
85
1063
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
12
6.94
3.72
1.5
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
97
1199
0.54
3.62
4.8
5.2
mmol/l
2.8
2.6
0.44
88
1091
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
9
8.06
3.59
2.6
2.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
82
578
1.83
3.58
7.2
5.5
e9/l
0.2
0.2
0.54
73
505
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
93
1162
0.54
3.56
5.6
4.7
mmol/l
6.0
6.1
0.22
82
1043
(3003694) ABO and Rh group [Type] in Blood
45
263
1.98
3.48
1.5
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
90
1126
0.56
3.30
4.3
4.2
mmol/l
1.3
1.3
0.30
80
1021
(3013826) Glucose [Moles/volume] in Serum or Plasma
92
683
1.78
3.29
7.2
4.1
mmol/l
7.0
6.9
0.27
87
630
(3006315) Basophils [#/volume] in Blood
79
561
1.78
3.29
7.1
5.3
e9/l
0.0
0.0
1.53
68
494
(3019198) Lymphocytes [#/volume] in Blood
80
571
1.78
3.27
7.0
5.3
e9/l
1.5
1.8
2.54
69
505
(3032080) INR in Blood by Coagulation assay
70
483
1.78
3.19
6.2
10.0
inr
1.2
1.4
1.09
20
133
(3000494) Fungus identified in Specimen by Culture
28
141
2.19
3.19
1.5
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
51
321
1.85
3.13
6.1
3.3
ph
7.4
7.4
1.18
12
52
(3001604) Monocytes [#/volume] in Blood
78
558
1.75
3.12
7.0
5.3
e9/l
0.6
0.6
0.22
67
490
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
5
10.25
3.00
2.2
1.6
ug/l
16.7
24.7
—
5
5
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
5
10.25
3.00
1.8
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
35
3.30
2.99
1.3
4.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
22
103
2.31
2.97
1.7
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
57
377
1.78
2.96
2.4
2.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
22
4.26
2.93
1.3
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
9
6.86
2.89
1.2
1.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
25
126
2.16
2.84
1.8
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
17
72
2.52
2.83
1.2
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
8
18
4.61
2.83
6.5
2.3
u/ml
30.5
9.7
—
8
12
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
18
4.61
2.83
1.5
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
92
1120
0.60
2.66
6.2
6.4
mmol/mol
40.7
40.9
0.06
82
1029
(3016018) Differential panel - Cerebral spinal fluid
6
11
5.61
2.56
1.7
1.0
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
5
7
7.32
2.56
1.8
1.7
mg/l
2.2
3.3
—
5
7
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
7
7.32
2.56
1.6
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
50
332
1.73
2.51
2.6
2.7
e6/l
17.6
284.6
0.76
41
256
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
16
4.52
2.50
1.1
3.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
21
106
2.12
2.38
1.9
2.8
e9/l
69.7
63.7
0.32
16
85
(3026782) Osmolality of Urine
34
205
1.83
2.35
2.4
2.7
mosm/kgh2o
546.7
568.7
0.18
27
164
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
19
3.80
2.17
1.3
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
22
118
2.00
2.14
5.1
3.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
10
5.12
2.08
1.4
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
10
5.12
2.08
1.4
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
10
5.12
2.08
1.4
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
10
5.12
2.08
1.4
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
10
5.12
2.08
1.4
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
10
5.12
2.08
1.4
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
20
3.61
2.08
5.3
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
44
2.61
2.06
1.1
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
15
4.11
2.06
1.0
1.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
13
58
2.35
1.96
2.2
1.4
g/l
2.4
1.2
0.55
13
53
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
16
3.85
1.95
1.0
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
6
16
3.85
1.95
2.3
2.5
%
205.0
186.5
—
6
16
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
16
3.85
1.95
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
22
3.28
1.90
1.6
1.0
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
8
29
2.85
1.81
5.3
1.2
mg/l
62.5
31.1
—
8
24
(3000850) Epithelial cells [#/volume] in Urine
33
214
1.68
1.78
2.6
2.3
e6/l
6.2
5.0
0.18
27
186
(3019225) pH of Specimen
21
119
1.88
1.76
4.6
3.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
13
3.93
1.72
2.8
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
28
421
0.60
1.70
6.3
4.0
mg/mmol
8.3
6.8
0.09
19
275
(3024928) Oxygen saturation in Venous blood
6
19
3.24
1.67
1.5
3.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
25
2.88
1.67
1.6
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
26
396
0.59
1.66
5.0
3.2
mg/l
46.2
205.1
0.52
19
267
(3030467) Casts [#/volume] in Urine by Automated count
42
295
1.57
1.65
2.3
2.6
e6/l
0.3
0.5
0.40
32
215
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
14
3.65
1.62
1.0
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
8
32
2.57
1.62
1.6
1.3
e6/l
4649.1
3848.0
—
8
25
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
8
32
2.57
1.62
1.6
1.2
e6/l
68.0
5.9
—
8
25
(3018095) Leukocytes [#/volume] in Urine
51
379
1.50
1.55
3.2
3.3
e6/l
26.2
98.8
1.60
42
272
(3009508) Creatinine [Moles/volume] in Urine
28
410
0.62
1.51
4.8
3.1
mmol/l
9.4
7.9
0.50
23
342
(3042631) Mycobacterium sp identified in Specimen
5
16
3.19
1.45
1.4
3.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
16
3.19
1.45
1.6
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
14
74
1.97
1.44
2.5
1.9
g/l
8.2
10.7
1.89
14
66
(3031040) Bacteria [#/volume] in Urine by Automated count
86
715
1.42
1.43
3.6
4.2
e6/l
67.6
352.4
—
5
11
(3034860) Kappa light chains.free [Mass/volume] in Serum
7
29
2.47
1.41
5.9
1.2
mg/l
23.6
46.8
—
7
24
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
34
236
1.56
1.40
2.9
3.8
ng/l
163.8
202.2
0.09
28
184
(3037756) Immunofixation for Serum or Plasma
6
23
2.67
1.38
3.0
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
17
3.00
1.37
3.4
2.1
e9/l
2.4
5.5
—
5
17
(3021589) Normoblasts [#/volume] in Blood
60
473
1.42
1.32
13.8
8.4
e9/l
0.0
0.0
0.91
54
385
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
18
2.83
1.29
4.4
3.3
%
64.0
61.1
—
5
18
(3019230) Fractional oxyhemoglobin in Venous blood
5
18
2.83
1.29
1.0
2.2
%
56.6
63.7
—
5
18
(36304419) Bacteria [Presence] in Urine
38
276
1.49
1.27
2.1
2.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
21
316
0.62
1.26
1.3
1.7
mmol/l
1.2
1.4
0.46
14
264
(3015736) pH of Urine
31
427
0.66
1.25
3.6
3.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
10
49
2.11
1.25
3.0
4.4
mmol/l
26.3
24.5
—
10
41
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
27
183
1.57
1.23
2.6
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
95
1077
0.72
1.23
6.3
4.3
mu/l
2.3
2.0
0.97
84
960
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
19
2.68
1.22
3.0
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
19
2.68
1.22
1.4
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
39
2.10
1.17
1.8
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
20
2.54
1.16
2.8
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
20
2.54
1.16
1.4
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
20
128
1.64
1.15
2.4
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
26
178
1.55
1.14
1.5
1.3
g/l
2.4
2.7
0.37
20
107
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
20
129
1.63
1.12
2.4
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
13
75
1.80
1.06
2.0
1.4
—
—
—
0
0
(3000492) Spirometry study
14
83
1.75
1.05
1.2
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
38
287
1.42
1.04
1.9
2.0
mg/l
3.0
3.1
0.08
31
241
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
69
1.80
0.99
1.3
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
24
168
1.50
0.96
2.0
2.5
e6/l
1.8
2.9
0.38
16
90
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
37
1.93
0.95
2.3
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
32
239
1.42
0.94
1.7
1.6
mg/l
1.2
1.1
0.08
26
175
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
5
105
0.46
0.92
2.6
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
13
79
1.70
0.91
3.5
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
42
1.95
0.90
1.3
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
31
401
0.72
0.87
3.4
3.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
13
81
1.66
0.84
3.6
5.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
46
557
0.76
0.83
4.8
3.8
ug/l
1.7
2.1
1.04
41
490
(3001122) Ferritin [Mass/volume] in Serum or Plasma
54
451
1.29
0.78
2.0
2.5
ug/l
195.1
126.3
0.98
48
414
(3012544) pH of Venous blood
17
116
1.52
0.78
4.0
3.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
54
452
1.29
0.76
2.0
2.1
nmol/l
77.2
76.4
0.08
49
403
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
60
1.71
0.74
2.4
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
14
93
1.55
0.72
3.6
2.1
ml/min/173m2
74.0
61.0
—
6
33
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
26
1.95
0.71
1.0
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
10
61
1.68
0.70
1.2
1.3
u/ml
123.7
246.0
—
10
56
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
42
1.70
0.69
3.6
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
86
771
1.24
0.67
4.4
4.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
11
164
0.65
0.65
13.8
7.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
30
1.69
0.62
3.0
2.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
8
51
1.60
0.61
1.1
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
20
0.00
0.61
0.0
3.8
—
41.5
—
0
6
(40768797) Stomach Pathology biopsy report
19
143
1.37
0.55
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
38
1.60
0.55
2.0
4.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
13
91
1.47
0.55
4.7
2.8
kpa
4.5
4.7
0.14
13
86
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
6
39
1.56
0.53
5.7
1.1
g/l
37.2
38.7
—
6
32
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
39
1.56
0.53
5.7
1.1
g/l
11.9
10.0
—
6
34
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
57
644
0.82
0.53
3.0
2.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
48
551
0.82
0.52
4.0
3.7
estimate
0.0
0.0
0.00
11
94
(3020630) Protein [Mass/volume] in Serum or Plasma
13
92
1.45
0.52
3.7
2.1
g/l
67.7
67.7
0.01
13
84
(3022145) Colonoscopy Study observation
13
93
1.43
0.50
1.8
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
80
728
1.19
0.49
3.1
2.9
u/l
56.7
49.3
0.37
75
675
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
83
0.59
0.47
1.4
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
24
294
0.79
0.46
2.9
2.6
ug/l
0.7
0.8
0.38
15
198
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
46
400
1.21
0.46
2.6
3.2
ng/l
502.3
1706.0
6.10
41
342
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
18
139
1.33
0.46
1.2
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
20
250
0.77
0.45
1.9
3.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
31
1.63
0.43
2.0
2.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
31
1.63
0.43
1.6
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
8
56
1.45
0.43
2.1
3.3
mmol/l
26.7
24.8
—
8
51
(3044889) 12 lead EKG panel
76
824
0.86
0.41
4.8
3.9
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
119
1246
0.84
0.41
32.2
14.9
umol/l
79.8
82.3
0.22
119
1246
(3000330) Specific gravity of Urine by Test strip
8
59
1.37
0.41
1.9
3.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
48
540
0.84
0.41
4.0
3.7
estimate
0.0
0.0
—
9
94
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
48
539
0.85
0.40
5.0
5.1
estimate
0.0
0.0
—
10
95
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
20.4
—
0
5
(3004775) Volume in Urine collected for unspecified duration
0
18
0.00
0.40
0.0
2.3
—
618.6
—
0
11
(4062490)
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
9
67
1.36
0.39
1.9
3.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
29
246
1.22
0.37
1.6
1.8
nmol/l
977.3
1192.7
0.69
22
191
(21494755) Public health laboratory ask at order entry panel
5
78
0.63
0.36
1.2
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
5
79
0.62
0.36
1.2
1.3
—
50.3
—
0
6
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
121
1157
1.17
0.36
28.8
12.8
mg/l
29.3
25.2
0.67
110
875
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
6
43
1.41
0.35
2.0
2.4
u/l
32.7
42.2
—
6
37
(40761511) CBC panel - Blood by Automated count
117
1220
0.86
0.34
23.6
12.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
46
1.32
0.33
5.7
1.3
g/l
7.4
7.7
—
6
35
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
46
1.32
0.33
5.7
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
46
1.32
0.33
5.7
1.3
g/l
3.0
3.0
—
6
34
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
46
1.32
0.33
5.7
1.3
g/l
3.2
3.9
—
6
33
(40761535) Cells panel - Urine sediment
7
97
0.71
0.32
2.1
3.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
39
434
0.87
0.29
4.1
3.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
28
244
1.18
0.28
5.4
4.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
39
432
0.87
0.27
5.8
3.7
%
23.4
24.0
0.08
17
205
(3022621) pH of Urine by Test strip
8
66
1.22
0.27
1.5
2.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
71
0.70
0.26
1.2
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
71
0.70
0.26
1.2
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
21
179
1.20
0.26
1.8
2.3
e6/l
0.9
1.0
0.03
11
101
(3023103) Potassium [Moles/volume] in Serum or Plasma
120
1240
0.88
0.26
30.9
15.4
mmol/l
4.0
4.0
1.16
114
1190
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
39.4
—
0
6
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(4146454)
0
10
0.00
0.21
0.0
3.8
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
48
517
0.90
0.21
3.5
4.0
ng/l
35.4
114.6
0.66
35
388
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
4.0
—
0
7
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
1.1
—
0
6
(4027681)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
14
0.00
0.20
0.0
1.0
—
7.9
—
0
8
(3028707) Methadone [Presence] in Urine by Screen method
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
106
1096
0.91
0.20
28.4
11.5
ml/min/173m2
81.9
76.4
2.03
96
874
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
7
62
1.13
0.17
2.6
2.3
%
0.8
1.1
—
7
62
(3003338) MCHC [Mass/volume]
94
970
0.93
0.15
33.5
16.5
g/l
330.7
332.5
1.01
94
960
(3037522) Nuclear Ab [Titer] in Serum
12
139
0.85
0.14
1.7
1.4
—
730.8
—
0
37
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
10
118
0.84
0.14
1.2
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
23
253
0.89
0.14
2.7
4.2
kg/l
1.0
1.0
—
5
34
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
100
0.79
0.14
1.8
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
100
1027
0.93
0.13
27.3
13.2
%
36.3
40.0
2.07
70
668
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
10
86
1.17
0.11
2.0
2.9
mmol/l
4.6
1.5
—
5
59
(3009343) pH of Capillary blood
10
87
1.16
0.09
2.1
2.9
—
7.4
—
0
9
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
60
0.83
0.08
2.2
2.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
49
507
0.95
0.07
2.0
1.9
pmol/l
88.1
93.8
0.39
30
270
(3029937) Albumin [Presence] in Urine by Test strip
29
305
0.94
0.07
4.7
3.9
estimate
0.0
0.0
0.00
11
91
(4010399)
8
93
0.85
0.07
1.4
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
30
287
1.06
0.05
1.7
1.5
nmol/l
15.9
20.6
1.03
25
249
(3002385) Erythrocyte distribution width [Ratio]
92
934
0.97
0.05
34.7
14.9
%
14.3
13.8
2.04
92
910
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
10
91
1.11
0.04
2.2
2.8
kpa
5.1
4.9
—
10
84
(40761536) Microorganisms panel - Urine sediment
10
91
1.11
0.04
8.6
3.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
29
301
0.96
0.04
4.9
3.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
87
859
1.03
0.03
5.4
3.6
pmol/l
14.1
15.0
2.23
79
779
(3013512) EKG study
38
384
0.99
0.00
3.8
4.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
32
315
1.02
0.00
2.7
3.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
14.1
—
0
6
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
8.0
—
803.2
—
0
5
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
7.7
—
0.6
—
0
6
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
6
0.00
0.00
0.0
1.2
—
1.7
—
0
6
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806420)
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
8
0.00
0.00
0.0
2.0
—
11.9
—
0
8
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
30.6
—
0
5
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
24.2
—
0
5
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
2.1
—
0
6
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
152.1
—
0
7
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
62
0.97
0.00
1.0
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
8
0.00
0.00
0.0
2.8
—
19.3
—
0
8
(3005033) Fetal Nuchal fold Thickness US
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
21.8
—
1117.8
—
0
5
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
5
0.00
0.00
0.0
3.4
—
13.9
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_ACCESSORY_SINUS_EXALLC – Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).